inxn-4001
Gene therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 9, 2018 (NCT03409627)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Neuropilin-1Supplementation
NRP1 supplementation
- Stromal cell-derived factor 1Supplementation
CXCL12 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03409627 | Phase 1 | Apr 9, 2018 | Intrexon, University of Arizona, Yeshiva University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Intrexon | For profit | 1 | 1 | 1 | 2018 |
| University of Arizona | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1